When Kailera revealed its plans for an IPO last month, there was a feeling that it could be huge – and that expectation has ...

The revitalisation of GSK's Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple ...

The global pharmaceutical industry has contended with many supply challenges in recent years, from the COVID-19 pandemic to ...

The months-long absence of permanent leadership at the CDC could soon be at an end, after President Trump nominated former ...

In our final video from the LSX World Congress in Lisbon, Portugal, web editor Nicole Raleigh spoke with Paulo Neves, CMO of ...

These documents are written in dense, lawyer-like language that requires individual interpretation from each function; ...

In its announcement, OpenAI called GPT-Rosalind a "frontier reasoning model built to support research across biology, drug ...

The UK has made progress in its efforts to slash set-up times for clinical trials, one of the factors blamed for a decline in ...

The ABPI, in the 3 rd March blog by Pinchas Kahtan, highlighted “early signs of a modest recovery in clinical trial ...

The British Business Bank (BB) has agreed to make a £100 million investment in a new healthcare fund launched by London-based ...

With one approved drug (Johnson & Johnson’s Spavaro) already doing $468 million per quarter in sales, and with companies like ...

A review of clinical data on amyloid beta-targeting Alzheimer's disease therapies has concluded their efficacy is too modest ...